Published in Nanomedicine (Lond) on June 01, 2013
Nanoparticle Uptake: The Phagocyte Problem. Nano Today (2015) 0.84
Cationic nanocarriers induce cell necrosis through impairment of Na(+)/K(+)-ATPase and cause subsequent inflammatory response. Cell Res (2015) 0.83
Effect of nano-scale curvature on the intrinsic blood coagulation system. Nanoscale (2014) 0.78
Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation. Angew Chem Int Ed Engl (2015) 0.78
Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets. Biochem Res Int (2016) 0.77
In vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers. Theranostics (2016) 0.75
Transfection Studies with Colloidal Systems Containing Highly Purified Bipolar Tetraether Lipids from Sulfolobus acidocaldarius. Archaea (2017) 0.75
Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer. Biomaterials (2016) 0.75
Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation. Curr Med Chem (2016) 0.75
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater (2009) 11.95
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol (2005) 7.28
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci (2003) 6.95
Passage of inhaled particles into the blood circulation in humans. Circulation (2002) 5.97
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci (2003) 5.73
Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med (1999) 4.72
Mechanisms of thrombus formation. N Engl J Med (2008) 4.67
Exposure to particulate air pollution and risk of deep vein thrombosis. Arch Intern Med (2008) 3.96
Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med (2005) 3.36
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release (2000) 3.07
Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small (2007) 3.05
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res (2010) 2.70
Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol (2005) 2.56
The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med (2008) 2.37
Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett (2006) 2.36
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano (2009) 2.36
Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small (2009) 2.27
Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol (2005) 2.27
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small (2009) 2.20
Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol (2002) 2.19
Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation (2003) 2.12
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res (2002) 2.09
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine (2008) 1.99
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano (2011) 1.90
Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study. J Expo Anal Environ Epidemiol (2005) 1.82
Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am J Respir Crit Care Med (2000) 1.75
Exposure to concentrated ambient air particles alters hematologic indices in humans. Inhal Toxicol (2003) 1.75
Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med (2005) 1.72
Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett (2004) 1.70
The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett (2006) 1.52
Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress. Occup Environ Med (2007) 1.49
Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.46
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer (2003) 1.38
Characterization of antiplatelet properties of silver nanoparticles. ACS Nano (2009) 1.37
Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect (2008) 1.32
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci (2005) 1.29
Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials (2010) 1.25
Health hazards due to the inhalation of amorphous silica. Arch Toxicol (2002) 1.24
Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation (2004) 1.22
Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett (2009) 1.22
Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res (2005) 1.21
Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology (2008) 1.19
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology (2011) 1.17
Particulate matter in the environment: pulmonary and cardiovascular effects. Curr Opin Pulm Med (2007) 1.15
The role of nanoparticle size in hemocompatibility. Toxicology (2009) 1.10
Blood coagulation on biomaterials requires the combination of distinct activation processes. Biomaterials (2009) 1.09
The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces. Biomaterials (2012) 1.08
An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology (2011) 1.06
A microanalytic study of particles transport across the alveoli: role of blood platelets. Biomedicine (1977) 1.05
Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects. Int J Nanomedicine (2011) 1.04
Disseminated intravascular coagulation in infectious disease. Semin Thromb Hemost (2010) 1.02
Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology (2012) 1.02
Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol Pharm (2011) 1.01
Potential in vitro effects of carbon nanotubes on human aortic endothelial cells. Toxicol Appl Pharmacol (2009) 0.99
Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. Toxicology (2009) 0.97
Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules (2007) 0.97
Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis. Int J Nanomedicine (2012) 0.95
Interactions of human endothelial cells with gold nanoparticles of different morphologies. Small (2011) 0.95
Pulmonary exposure to diesel exhaust particles induces airway inflammation and cytokine expression in NC/Nga mice. Arch Toxicol (2005) 0.93
Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells. Toxicol Appl Pharmacol (1999) 0.93
Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials (2011) 0.92
Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials (2011) 0.92
Size effects of latex nanomaterials on lung inflammation in mice. Toxicol Appl Pharmacol (2008) 0.91
Phagocytosis of liposomes by human platelets. Proc Natl Acad Sci U S A (1992) 0.90
Propofol versus sevoflurane: bleeding in endoscopic sinus surgery. Otolaryngol Head Neck Surg (2007) 0.90
Cationic PAMAM dendrimers disrupt key platelet functions. Mol Pharm (2012) 0.90
Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett (2009) 0.89
Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge. Nanomedicine (Lond) (2011) 0.87
Negative regulation of fibrin polymerization and clot formation by nanoparticles of silver. Colloids Surf B Biointerfaces (2010) 0.86
Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response. J R Soc Interface (2009) 0.86
Quantum dots hold promise for early cancer imaging and detection. Int J Cancer (2012) 0.86
Promoting effects of nanoparticles/materials on sensitive lung inflammatory diseases. Environ Health Prev Med (2010) 0.85
Aggravating impact of nanoparticles on immune-mediated pulmonary inflammation. ScientificWorldJournal (2011) 0.85
Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology (2010) 0.85
Pulmonary biocompatibility assessment of inhaled single-wall and multiwall carbon nanotubes in BALB/c mice. J Biol Chem (2011) 0.84
Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano (2011) 0.84
Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles. J Thromb Haemost (2010) 0.84
Interaction of RGD liposomes with platelets. Biochem Biophys Res Commun (1996) 0.83
Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology. Nanomedicine (Lond) (2013) 0.82
Assessment of thrombogenic potential of liposomes. Toxicology (1989) 0.82
Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine (Lond) (2010) 0.81
Polystyrene nanoparticles affecting blood coagulation. Nanomedicine (2011) 0.81
Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells. Nanotoxicology (2010) 0.81
Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. J Control Release (2009) 0.81
Liposomes and blood cells: a flow cytometric study. Artif Cells Blood Substit Immobil Biotechnol (2003) 0.80
Interactions of conventional or photopolymerized liposomes with platelets in vitro. Exp Cell Res (1983) 0.80
Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells. Endothelium (2008) 0.79
Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro. Toxicol Sci (2010) 0.79
Multistability in platelets and their response to gold nanoparticles. Nanomedicine (2011) 0.79
Interactions of liposomes and platelets. Thromb Haemost (1988) 0.78
Bioeffects of CdTe quantum dots on human umbilical vein endothelial cells. J Nanosci Nanotechnol (2010) 0.78
A second-generation blood substitute (Perfluorodichlorooctane emulsion) generates spurious elevations in platelet counts from automated hematology analyzers. Anesth Analg (2000) 0.77
Fibrinogen clot induced by gold-nanoparticle in vitro. J Nanosci Nanotechnol (2011) 0.76
Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood. Artif Cells Blood Substit Immobil Biotechnol (1995) 0.76
Present status of clinical studies of Fluosol-DA (20%) in Japan. Int Anesthesiol Clin (1985) 0.76
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
Nanoparticles and the immune system. Endocrinology (2009) 1.79
Characterization of nanoparticles for therapeutics. Nanomedicine (Lond) (2007) 1.62
Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory. Integr Biol (Camb) (2013) 1.30
Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat Protoc (2011) 1.27
Identification and avoidance of potential artifacts and misinterpretations in nanomaterial ecotoxicity measurements. Environ Sci Technol (2014) 0.95
Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays. Methods Mol Biol (2011) 0.92
Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro. Nanomedicine (Lond) (2011) 0.89
Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles. ACS Nano (2014) 0.88
Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology. Nanomedicine (Lond) (2013) 0.82
Quantitative characterization of quantum dot-labeled lambda phage for Escherichia coli detection. Biotechnol Bioeng (2009) 0.82
Qualitative analysis of total complement activation by nanoparticles. Methods Mol Biol (2011) 0.81
In vitro analysis of nanoparticle uptake by macrophages using chemiluminescence. Methods Mol Biol (2011) 0.81
Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity. Nanomedicine (Lond) (2013) 0.80
Gold nanoparticle quantitation via fluorescence in solution and cell culture. Methods Mol Biol (2011) 0.79
Method for analysis of nanoparticle hemolytic properties in vitro. Methods Mol Biol (2011) 0.77
Method for in vitro analysis of nanoparticle thrombogenic properties. Methods Mol Biol (2011) 0.76
Method for analysis of nanoparticle effects on cellular chemotaxis. Methods Mol Biol (2011) 0.75
Application of a Scavenger Receptor A1 Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV. Mol Pharm (2020) 0.75
Analysis of microbial contamination in nanoparticle formulations. Methods Mol Biol (2011) 0.75
A novel cell-based system for the rapid quantitative evaluation of (anti)-inflammatory potential of test substances. J Immunol Methods (2003) 0.75